Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resting natural killer cells promote the progress of colon cancer liver metastasis by elevating tumor-derived stem cell factor. | Elife | 2024 | 39387546 | PubTator, text mining | PubMed |
| Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma. | Hepatobiliary Surg Nutr | 2024 | 39175731 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis uncovers heterogeneity in the labial gland microenvironment of primary Sjögren's syndrome. | J Transl Autoimmun | 2024 | 39131726 | PubTator, text mining | PubMed |
| Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression. | Signal Transduct Target Ther | 2024 | 39090109 | PubTator, text mining | PubMed |
| NKT cells promote Th1 immune bias to dengue virus that governs long-term protective antibody dynamics. | J Clin Invest | 2024 | 39088280 | PubTator, text mining | PubMed |
| Risk prediction model of uterine corpus endometrial carcinoma based on immune-related genes. | BMC Womens Health | 2024 | 39068426 | PubTator, text mining | PubMed |
| Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance. | NPJ Precis Oncol | 2024 | 39060379 | PubTator, text mining | PubMed |
| Fe3O4@R837 Nanoplatform Enhances Chemical Dynamic Therapy and Immunotherapy: Integrated Transcriptomic Analysis Reveals Key Genes in Breast Cancer Prognosis. | ACS Biomater Sci Eng | 2024 | 39056174 | PubTator, text mining | PubMed |
| Characteristics and functions of an atypical inflammation-associated GZMK+GZMB+CD8+ T subset in people living with HIV-1. | Mol Immunol | 2024 | 39053388 | PubTator, text mining | PubMed |
| Single-Cell Analysis Identifies Distinct Populations of Cytotoxic CD4+ T Cells Linked to the Therapeutic Efficacy of Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma. | J Inflamm Res | 2024 | 39006494 | PubTator, text mining | PubMed |
| Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodes. | Oncoimmunology | 2024 | 38979545 | PubTator, text mining | PubMed |
| Validating the temporal performance of genetic biomarkers in an animal model of recurrence/ non-recurrence myocardial infarction persuades by bioinformatics tools. | Eur J Pharmacol | 2024 | 38950836 | PubTator, text mining | PubMed |
| scPLAN: a hierarchical computational framework for single transcriptomics data annotation, integration and cell-type label refinement. | Brief Bioinform | 2024 | 38935069 | PubTator, text mining | PubMed |
| Peripheral Blood CD8+ T-Lymphocyte Immune Response in Benign and Subpopulations of Breast Cancer Patients. | Int J Mol Sci | 2024 | 38928129 | PubTator, text mining | PubMed |
| Granzyme K mediates IL-23-dependent inflammation and keratinocyte proliferation in psoriasis. | Front Immunol | 2024 | 38903528 | PubTator, text mining | PubMed |
| Ragas: integration and enhanced visualization for single cell subcluster analysis. | Bioinformatics | 2024 | 38867706 | PubTator, text mining | PubMed |
| Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium. | Nat Commun | 2024 | 38862501 | PubTator, text mining | PubMed |
| Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue. | Cell Discov | 2024 | 38834551 | PubTator, text mining | PubMed |
| Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes. | J Cancer Res Clin Oncol | 2024 | 38833021 | PubTator, text mining | PubMed |
| Granzyme K drives a newly-intentified pathway of complement activation. | bioRxiv | 2024 | 38826230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=14